查看原文
其他

拟上市细胞治疗公司招聘CSO

吴红岩 医药荐客 2023-12-24
公司背景:
  • 公司致力于细胞创新药物研发、生产和销售。
  • 公司以开发血液肿瘤细胞类药物和抗体药物为主,拥有完整的从早期发现、临床开发、注册申报到商业化生产的全流程能力。
  • 公司已完成多轮融资,并签署上市辅导协议,拟科创板挂牌上市


Job Responsibilities:

•Set strategy for discovery and preclinical R&D efforts in cell therapy and biologic fields, taking into account both cutting edge sciences and internal strengths to address unmet medical needs and realize commercial potential of therapies.

•Build a project pipeline through internal R&D, collaboration, license-in and/or acquisition in the field. Select the projects based on scientific merit, strategic fit and economic value.

•Assemble/ manage a team of talented scientists to execute on the development strategy. Motivate team members, manage team operations to ensure project progress.

•Drive the progress of pipeline projects and collaborations according to agreed upon timelines.

•Lead or participate business development efforts, working with other colleagues to assess the quality and fit of external assets. Help company management make decisions on asset acquisition or collaboration.

•Stay connected with scientific community, stay up to date with the latest scientific discovery and industry trends, stay alert about potential technology--driven opportunities and alerts from competitors.

•Work collaboratively with internal and external cross--functional teams, collaborators/consultants to plan and execute on the overall research and development plans.

•Participate in business initiatives that further the strategic and business objectives of the company.

•Communicate program progress and issues to senior management, regulatory agencies as necessary, and at national and international conferences as appropriate.

Required Skills & Qualifications:

1.15+ years of industry experience in the biopharmaceutical industry with 5+ years in Senior leadership/managerial positions. Prior experience in the field of immunology of tumor required. Ideally with 8+ years experience working at cell therapy field;

2.PhD in Immunology related major required;

3. Proved success track record of advancing discovery projects into early clinical development.

4. Extensive leadership and management skills ideally developed in Big Pharma or high profile cell therapy(Start-up) companies;

5.Effective interpersonal skills. Prior experience with establishing and advancing industry partnerships strongly desired;

6. Ability to work in a fast-paced, start-up environment, Results oriented, high execution;

7. International travel as needed for up to 20% of the time, including US and/China.

职位资讯
中美生物医药岗位汇总-202305
招聘分支和关节等疾病领域人才(药理和临床药理学)
质谱公司招聘CEO
上市公司招聘细胞治疗全球研发SVP, 中美俩地工作
公司招聘上市研发质量分析副总监,短暂合成和新剂型博士
招聘首席医学官CMO
广东药企招聘商务总监及融资总监
公司上市招聘美国BD-WFH
招聘药物化学高级经理到联合创始人级别(ADC/PROTAC/离子)
招聘酵母和工程菌发酵博士

商务资讯
登记-结直肠癌分子诊断项目
早期项目移植:小分子脑瘤和中枢神经系统新药
2023年11月国内生物医药投资融资汇总
2023年10月国内生物医药投资融资汇总

行业资讯
Biotech的苦日子,为什么换来CRO的好日子
工信部2022年度中国医药工业百强榜
寒冬风险评估指南,如何规避和降低职业?
2023中国溶瘤病毒产业发展蓝皮书
综述:多肽改性(TPD):PROTAC、LYTAC、分子胶、光控PROTAC...
2022年全球医药并购总结
ADC的迭代史盘点:中国的62家合成生物企业外泌体行业分析报告类器官与器官芯片行业白皮书:全球49家企业,未来是CRO还是Biotech?
核药行业白皮书:整理全球近7000条饲料,在靶点、配体、核素创新中竞赛《置身科学内》 - 从PhD到BD(想转BD的预览来)
继续滑动看下一个

您可能也对以下帖子感兴趣

文章有问题?点此查看未经处理的缓存